Results 181 to 190 of about 4,963,319 (355)
Coronary microvascular dysfunction (CMD) targeting remains a challenge for precise diagnosis. This work presents a dual‐modal nanoprobe (T‐IR780‐NBs) that combines ultrasound contrast with near‐infrared fluorescence. This technology utilizes proteomics‐derived antibodies that specifically localize to inflamed and injured cardiac tissue, enabling ...
Xiaohui Xu +6 more
wiley +1 more source
Clinical Outcomes and Challenges in the Management of Spondylodiscitis in Patients With Intravenous Drug Abuse: A Multicenter Retrospective Study. [PDF]
Albrecht C +9 more
europepmc +1 more source
This study develops a placenta‐targeted nanodelivery system co‐loading HMGB1 protein and the NLRP3 agonist nigericin to establish an animal model of atonic postpartum hemorrhage. The model accurately recapitulates clinical phenotypes, including prolonged labor and uterine contractility dysfunction, while revealing inflammatory activation in placental ...
Jiangxue Qu +10 more
wiley +1 more source
Candida tropicalis-Associated Osteomyelitis in an Intravenous Drug User: A Case Report. [PDF]
Ubanatu CB, Appiah JK, Barry C.
europepmc +1 more source
Assessment of Bacterial Infections and Antibiotic Regimens in Intravenous Drug Users. [PDF]
Rehman S +6 more
europepmc +1 more source
As implantable medical devices become indispensable to modern medicine, a silent threat grows alongside them: device‐associated infections. Despite decades of antibiotic innovation, infection rates keep climbing, costing lives and billions in healthcare expenses.
Benito Baldauf +5 more
wiley +1 more source
Infective Endocarditis Presenting As Meningeal Syndrome in an Intravenous Drug User: A Diagnostic Challenge. [PDF]
Fernandez Eng IL +4 more
europepmc +1 more source
Multifocal neuropathy and Horner's syndrome due to disseminated pyomyositis in an intravenous drug user. [PDF]
de Souza A, Liew BZ.
europepmc +1 more source

